ALR Technologies, Inc. engages in the provision of remote monitoring and care facilitation for patients with diabetes. The company is headquartered in Richmond, Virginia and currently employs 6 full-time employees. The company went IPO on 2000-03-13. The firm has developed an approach to diabetes care that includes the United States Food and Drug Administration (FDA) cleared diabetes management system, which collects data directly from blood glucose meters (BGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports, and an FDA-cleared Insulin Dosing Adjustment program. The firm has developed the Diabetes Solution for human health and the GluCurve, a modified version of the Diabetes Solution for animal health (GluCurve) from its technology portfolio. Its platform provides healthcare professionals (HCPs) with patient prioritization reports and alerts based on the Predictive A1C measures and other related diagnostics. Predictive A1C was designed to assist HCPs in addressing clinical inertia in diabetes care. The firm's wholly owned subsidiaries include ALR Technologies SG Pte. Ltd. and Canada Diabetes Solution Centre Inc.

Industry: Communications Equipment, NEC Peers: Abbott Laboratories Acutus Medical, Inc. REMSleep Holdings Inc Delcath Systems Inc Strata Skin Sciences Inc ENDRA Life Sciences Inc OMNIA WELLNESS INC. Heartbeam Inc MINERVA SURGICAL INC NeuroMetrix, Inc.